PPM1D and plasma cell myeloma: Moreover, the presence of DNMT3A and PPM1D mutations in stem cell grafts collected in myeloma patients correlated with reduced stem cell yields and delayed platelet count recovery following ASCT associated with impaired regeneration in ASCT recipients [18].